Form 8-K - Current report:
SEC Accession No. 0001193125-22-171023
Filing Date
2022-06-09
Accepted
2022-06-09 16:06:05
Documents
12
Period of Report
2022-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d366546d8k.htm   iXBRL 8-K 29437
  Complete submission text file 0001193125-22-171023.txt   154541

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sana-20220606.xsd EX-101.SCH 2835
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sana-20220606_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sana-20220606_pre.xml EX-101.PRE 11693
6 EXTRACTED XBRL INSTANCE DOCUMENT d366546d8k_htm.xml XML 3473
Mailing Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 221006002
SIC: 2836 Biological Products, (No Diagnostic Substances)